Scholar: Daniel Herranz

Daniel Herranz

Forever young: Sphk2 in HSCs, when less is more

Read More

Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia

  • Natalia Baran, Alessia Lodi, Yogesh Dhungana, …, Stefano Tiziani, Trang Hoang, Marina Konopleva
  • Nat Commun, 10.1038/s41467-022-30396-3
Read More

A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia

  • Victoria da Silva-Diz, Bin Cao, Olga Lancho, …, Xiaoyang Su, Shengkan Jin, Daniel Herranz
  • Blood, 10.1182/blood.2020008955
Read More

Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia

  • Huizhong Xiong, Maicol Mancini, Michael Gobert, …, Daniel Herranz, Juan J Lafaille, Antonio Maraver
  • Theranostics, 10.7150/thno.48067
Read More

SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia

  • Juan C García-Cañaveras, Olga Lancho, Gregory S Ducker, …, Hahn Kim, Daniel Herranz, Joshua D Rabinowitz
  • Leukemia, 10.1038/s41375-020-0845-6
Read More

The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer

Read More